Delivery Systems

23 registered clinical trials studyying Delivery Systems — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Determining the Viability a Lozenge Dosage for Probiotics NCT06819761	Ostia Sciences	EARLY_Phase 1
Completed	Investigation of Pain During Subcutaneous Injections With Different Injection Speed and Volume Combinations NCT01680328	Novo Nordisk A/S	Phase 1
Completed	Evaluating Safety of NovoPen® 3 and/or FlexPen® Devices in Routine Clinical Practice NCT01454024	Novo Nordisk A/S	—
Completed	Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated NCT01327924	Novo Nordisk A/S	—
Completed	Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents NCT01245374	Novo Nordisk A/S	Phase 4
Completed	Observational Study of NovoPen Echo® on Safety and Treatment Satisfaction in Children and Adolescents With Typ NCT01180530	Novo Nordisk A/S	—
Completed	Observational Study of NovoPen® 4 on Treatment Satisfaction of Insulin Therapy in Type 1 or Type 2 Subjects Wi NCT00806858	Novo Nordisk A/S	—
Completed	Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabe NCT00773279	Novo Nordisk A/S	Phase 3
Completed	Observational Study to Assess the Efficacy and Safety of NovoRapid™ Flexpen™ NCT00675220	Novo Nordisk A/S	—
Completed	Observational Study to Evaluate Safety, Efficacy and Convenience of Using NovoMix® 30 FlexPen® in Type 2 Diabe NCT00715663	Novo Nordisk A/S	—
Completed	Observational Study of Norditropin NordiFlex® With NordiFlex PenMate™ NCT01500486	Novo Nordisk A/S	—
Completed	Evaluation of Safety and Parameters of Application Technique NCT01516242	Novo Nordisk A/S	—
Completed	Comparison of NovoFine® Needles (4 mm vs. 6 mm) NCT00343343	Novo Nordisk A/S	Phase 2
Completed	Novofine Autocover Safety Needle Versus BD Safety Glide NCT00121355	Novo Nordisk A/S	Phase 4
Completed	Reliability of Dosing With NovoLog® Mix 70/30 FlexPen® Compared With Vial and Syringe NCT00127296	Novo Nordisk A/S	Phase 1
Completed	A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump NCT00115973	Novo Nordisk A/S	Phase 1
Completed	Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes NCT00184613	Novo Nordisk A/S	Phase 1
Completed	Evaluating the Use of Two Different Needles in Subjects With Diabetes NCT00569426	Novo Nordisk A/S	Phase 4
Completed	Preference Study Between NovoFine® Autocover™ and a NovoFine® 8 mm Needle NCT01024218	Novo Nordisk A/S	Phase 4
Completed	Comparison of Two Pen Systems in Patients With Diabetes Treated With Insulin NCT00569998	Novo Nordisk A/S	Phase 3
Completed	Comparison of Glycemic Control Achieved With 2 Different Needles NCT00572052	Novo Nordisk A/S	Phase 4
Completed	Comparison of 2 NovoFine® Needles on the Reflux of Insulin NCT00872560	Novo Nordisk A/S	Phase 3
Completed	Localisation of Potential Insulin Deposits in Normal Weight and Obese Diabetics Using 6 mm and 12 mm Long Need NCT00871416	Novo Nordisk A/S	Phase 3